China Regenerative Medicine International Ltd Sustainability Reports
The company operates as an investment holding company that develops, manufactures, and sells biomedical products, medical devices, and healthcare services. Its activities mainly focus on regenerative medicine, aesthetic medical services, and tissue engineering solutions.
Sector: Manufacturing
Country: Hong Kong
Exchange: Hong Kong Stock Exchange
FIGI: BBG001SJ8T94
5 reports from 2021 to 2025
- China Regenerative Medicine International Ltd 2025 Annual Report
- China Regenerative Medicine International Ltd 2025 Environmental, Social and Governance Report
- China Regenerative Medicine International Ltd 2024 Annual Report
- China Regenerative Medicine International Ltd 2022 Annual Report
- China Regenerative Medicine International Ltd 2021 Annual Report